Eli Lilly, telehealth firm team up to expand Zepbound access

Eli Lilly has partnered with the telehealth company Ro to expand access to single-dose vials of its popular weight loss drug Zepbound.

Read the full post on Becker's Hospital Review | Healthcare News & Analysis